Opportunity
Simpler Grants.gov #PAR-25-321
Bioengineering Research Grants for Cancer Research (NCI/NIH)
Buyer
National Institutes of Health
Posted
December 10, 2024
Respond By
January 07, 2028
Identifier
PAR-25-321
NAICS
541715, 541714, 541713
The National Cancer Institute (NCI), part of the National Institutes of Health (NIH), is inviting applications for exploratory and developmental Bioengineering Research Grants (EBRG) focused on cancer research. - Government Buyer: - National Institutes of Health (NIH), National Cancer Institute (NCI) - Purpose and Scope: - Supports engineering-oriented research projects addressing cancer-related challenges - Aims to demonstrate feasibility and utility of new or improved capabilities in biomedical, pre-clinical, or clinical research, and clinical care delivery - Focus areas include cancer treatment, detection, diagnosis, control, cause, prevention, and biology - Eligibility: - Open to government entities, nonprofits, businesses, educational institutions, and other organizations - Products/Services Requested: - No specific OEMs, vendors, products, or part numbers are identified - Seeks innovative research proposals rather than procurement of defined products or services - Notable Requirements: - No cost sharing or matching required - Emphasis on improvements in quality, speed, efficacy, operability, costs, and accessibility for cancer research and care - No specific quantities or line items are listed, as this is a research grant opportunity
Description
The National Cancer Institute (NCI) invites applications for exploratory/developmental Bioengineering Research Grants (EBRG) to demonstrate feasibility and potential utility of new capabilities or improvements in quality, speed, efficacy, operability, costs, and/or accessibility of solutions to problems in basic biomedical, pre-clinical, or clinical research, clinical care delivery, or accessibility. This funding opportunity supports engineering-oriented research to address challenges in cancer treatment, detection, diagnosis, control, cause, prevention, and biology. Eligible applicants include a wide range of government entities, nonprofits, businesses, educational institutions, and other organizations. The grant does not require cost sharing or matching and is categorized under health and education funding activities.